These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 20561529)

  • 1. Regulatory insertion removal restores maturation, stability and function of DeltaF508 CFTR.
    Aleksandrov AA; Kota P; Aleksandrov LA; He L; Jensen T; Cui L; Gentzsch M; Dokholyan NV; Riordan JR
    J Mol Biol; 2010 Aug; 401(2):194-210. PubMed ID: 20561529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correctors of ΔF508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein.
    He L; Kota P; Aleksandrov AA; Cui L; Jensen T; Dokholyan NV; Riordan JR
    FASEB J; 2013 Feb; 27(2):536-45. PubMed ID: 23104983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of NBD1 thermal stability is necessary and sufficient to correct ∆F508 CFTR folding and assembly.
    He L; Aleksandrov AA; An J; Cui L; Yang Z; Brouillette CG; Riordan JR
    J Mol Biol; 2015 Jan; 427(1):106-20. PubMed ID: 25083918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The most common cystic fibrosis-associated mutation destabilizes the dimeric state of the nucleotide-binding domains of CFTR.
    Jih KY; Li M; Hwang TC; Bompadre SG
    J Physiol; 2011 Jun; 589(Pt 11):2719-31. PubMed ID: 21486785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ΔF508-CFTR Modulator Screen Based on Cell Surface Targeting of a Chimeric Nucleotide Binding Domain 1 Reporter.
    Phuan PW; Veit G; Tan JA; Roldan A; Finkbeiner WE; Haggie PM; Lukacs GL; Verkman AS
    SLAS Discov; 2018 Sep; 23(8):823-831. PubMed ID: 29533733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR evidence for differential phosphorylation-dependent interactions in WT and DeltaF508 CFTR.
    Kanelis V; Hudson RP; Thibodeau PH; Thomas PJ; Forman-Kay JD
    EMBO J; 2010 Jan; 29(1):263-77. PubMed ID: 19927121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
    deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
    Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis transmembrane conductance regulator (CFTR) potentiators protect G551D but not ΔF508 CFTR from thermal instability.
    Liu X; Dawson DC
    Biochemistry; 2014 Sep; 53(35):5613-8. PubMed ID: 25148434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conserved allosteric hot spots in the transmembrane domains of cystic fibrosis transmembrane conductance regulator (CFTR) channels and multidrug resistance protein (MRP) pumps.
    Wei S; Roessler BC; Chauvet S; Guo J; Hartman JL; Kirk KL
    J Biol Chem; 2014 Jul; 289(29):19942-57. PubMed ID: 24876383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and dynamics of NBD1 from CFTR characterized using crystallography and hydrogen/deuterium exchange mass spectrometry.
    Lewis HA; Wang C; Zhao X; Hamuro Y; Conners K; Kearins MC; Lu F; Sauder JM; Molnar KS; Coales SJ; Maloney PC; Guggino WB; Wetmore DR; Weber PC; Hunt JF
    J Mol Biol; 2010 Feb; 396(2):406-30. PubMed ID: 19944699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase CK2, cystic fibrosis transmembrane conductance regulator, and the deltaF508 mutation: F508 deletion disrupts a kinase-binding site.
    Treharne KJ; Crawford RM; Xu Z; Chen JH; Best OG; Schulte EA; Gruenert DC; Wilson SM; Sheppard DN; Kunzelmann K; Mehta A
    J Biol Chem; 2007 Apr; 282(14):10804-13. PubMed ID: 17289674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of protein kinase CK2 closes the CFTR Cl channel, but has no effect on the cystic fibrosis mutant deltaF508-CFTR.
    Treharne KJ; Xu Z; Chen JH; Best OG; Cassidy DM; Gruenert DC; Hegyi P; Gray MA; Sheppard DN; Kunzelmann K; Mehta A
    Cell Physiol Biochem; 2009; 24(5-6):347-60. PubMed ID: 19910675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy.
    Hall JD; Wang H; Byrnes LJ; Shanker S; Wang K; Efremov IV; Chong PA; Forman-Kay JD; Aulabaugh AE
    Protein Sci; 2016 Feb; 25(2):360-73. PubMed ID: 26444971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure.
    Lewis HA; Zhao X; Wang C; Sauder JM; Rooney I; Noland BW; Lorimer D; Kearins MC; Conners K; Condon B; Maloney PC; Guggino WB; Hunt JF; Emtage S
    J Biol Chem; 2005 Jan; 280(2):1346-53. PubMed ID: 15528182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric coupling between the intracellular coupling helix 4 and regulatory sites of the first nucleotide-binding domain of CFTR.
    Dawson JE; Farber PJ; Forman-Kay JD
    PLoS One; 2013; 8(9):e74347. PubMed ID: 24058550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The primary folding defect and rescue of ΔF508 CFTR emerge during translation of the mutant domain.
    Hoelen H; Kleizen B; Schmidt A; Richardson J; Charitou P; Thomas PJ; Braakman I
    PLoS One; 2010 Nov; 5(11):e15458. PubMed ID: 21152102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.
    Du K; Sharma M; Lukacs GL
    Nat Struct Mol Biol; 2005 Jan; 12(1):17-25. PubMed ID: 15619635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric modulation balances thermodynamic stability and restores function of ΔF508 CFTR.
    Aleksandrov AA; Kota P; Cui L; Jensen T; Alekseev AE; Reyes S; He L; Gentzsch M; Aleksandrov LA; Dokholyan NV; Riordan JR
    J Mol Biol; 2012 May; 419(1-2):41-60. PubMed ID: 22406676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Scanning Fluorimetry and Hydrogen Deuterium Exchange Mass Spectrometry to Monitor the Conformational Dynamics of NBD1 in Cystic Fibrosis.
    Soya N; Roldan A; Lukacs GL
    Methods Mol Biol; 2019; 1873():53-67. PubMed ID: 30341603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A domain mimic increases DeltaF508 CFTR trafficking and restores cAMP-stimulated anion secretion in cystic fibrosis epithelia.
    Clarke LL; Gawenis LR; Hwang TC; Walker NM; Gruis DB; Price EM
    Am J Physiol Cell Physiol; 2004 Jul; 287(1):C192-9. PubMed ID: 15028554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.